{"database": "lobbying", "table": "lobbying_activities", "rows": [[1552357, "416efc63-174e-426a-b3a5-347cd1163b9e", "Q2", "AMERICAN CLINICAL LABORATORY ASSN", 1923, "AMERICAN CLINICAL LABORATORY ASSN", 2014, "second_quarter", "MED", "Reimbursement and coverage issues related to the Medicare Clinical Laboratory Fee Schedule and the Physician Fee Schedule, including implementation of the Protecting Access to Medicare Act of 2014(P.L. 113-93), misvalued codes, and pricing for molecular diagnostic tests by CMS. Proposed FDA regulation of laboratory-developed tests. Narrowing the In-Office Ancillary Services Exception to the federal self-referral statute to remove anatomic pathology, advanced diagnostic imaging, physical therapy, and radiation therapy services, H.R. 2914, the Promoting Integrity in Medicare Act of 2013. 21st Century Cures Initiative.", "Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Defense, Dept of (DOD),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office", null, 273317, 0, 0, "2014-07-16T10:55:02.500000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1552357"], "units": {}, "query_ms": 20.469612907618284, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}